Anna Betchel
Recent Articles
New Chapter 11 Filings, Disclosures: April 12 – April 16, 2021
At least two major companies have either filed for Chapter 11 bankruptcy protection or defaulted on loans during the week of April...
ViacomCBS Networks International Agrees to Acquire Chilevisión
On Monday April 5, ViacomCBS Inc. (NASDAQ: VIAC, VIACA) announced that it had agreed to acquire Chilevisión from WarnerMedia. WarnerMedia is a...
Carnival Reports $2 Billion Quarterly Loss
Carnival reports $2 billion quarterly loss. This is due to COVID-19 pandemic restrictions on the cruising industry, which has decimated Carnival and...
New High Yield Bond Ratings: April 5 – 9, 2021
At least 35 companies received a revision on high yield bond ratings during the week of April 5-9, 2021. These revisions caused...
ECB President Lagarde Expects Strong Rebound for EU Economy in Second Half
Despite COVID-19 struggles, European Central Bank (ECB) President Christine Lagarde told CNBC on April 9 that the European Union (EU) will hit...
Most Popular
Treasury Secretary Yellen Calls for Global Minimum Corporate Tax
U.S. Treasury Secretary Janet Yellen said on April 5 that she is working with G20 countries to agree on a global minimum...
Prelude Therapeutics Files for Its IPO
Prelude Therapeutics Incorporated files for its IPO. According to the S-1 filing, the IPO will see the company trade shares on the...
Shipping Giants Ride Coattails of Online Retail Surge
The COVID-19 pandemic has undoubtedly had a profound impact on the global economy, but those impacts have varied across sectors. While many...
Endologix Files for Chapter 11 Bankruptcy
Medical device company Endologix, Inc. initiated Chapter 11 bankruptcy on July 6. The California-based developer of treatments for aortic disorders also filed...
James Woody Explores New Horizons in Enosi Life Sciences
Enosi Life Sciences announced that it has appointed Dr. James Woody as its Executive Chairman. Having immense leadership skills, Dr. James holds over 25 years of experience in the pharmaceutical, venture capital, and biotech sectors. He also possesses medical expertise in antibody therapeutics and oncology.
